Terri is currently Deloitte’s Vice Chair of External Diversity, Equity, and Inclusion (DEI) where she focuses on fostering Deloitte’s external brand and helping to drive market facing efforts.
Terri has a personal passion and commitment to growing and developing talent at all levels. As chief inclusion officer, Terri drove Deloitte’s strategy to recruit, develop, and advance a diverse workforce and foster an inclusive environment. Terri led Deloitte’s inaugural Inclusion Summit and Day of Understanding, which fostered courageous conversations on DEI topics. She advanced inclusive leadership at all levels and establish inclusion as a core leadership capability.
Terri has more than two decades of experience working in various capacities of the life sciences and health care industry, including participating in a broad range of strategic advisory services. She has created new global operating models; supported the integration of development, regulatory, and drug safety functions in a number of Life Sciences company mergers; restructured all aspects of the research and development (R&D) value chain; and driven increased cost and efficiency measures.
Terri serves as a frequent speaker on diversity, equity, and inclusion issues and trends. She spearheaded the State of Inclusion annual research as well as represented Deloitte at Davos, Fortune’s Most Powerful Women, and Women Leaders Global Forum. She was named to Crain’s 2019 New York Notable Women in Accounting. She is a board member for the Simmons University Institute for Inclusive Leadership Strategic Board of Advisors.
She holds a Joint Honors Bachelor of Science Degree in Chemistry and Pharmacology and a PhD in Pharmacology from the University of London, UK.